{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T15:10:31Z","timestamp":1779894631170,"version":"3.53.1"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"45","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CPD"],"published-print":{"date-parts":[[2018,2,16]]},"DOI":"10.2174\/1381612823666171109101851","type":"journal-article","created":{"date-parts":[[2018,2,19]],"date-time":"2018-02-19T11:01:24Z","timestamp":1519038084000},"page":"7003-7024","source":"Crossref","is-referenced-by-count":9,"title":["Use of E. coli Purine Nucleoside Phosphorylase in the Treatment of Solid Tumors"],"prefix":"10.2174","volume":"23","author":[{"given":"William B.","family":"Parker","sequence":"first","affiliation":[{"name":"PNP Therapeutics Inc., Birmingham, AL, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Sorscher","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine, Atlanta, GA, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Pharmaceutical Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/156952","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,2,19]],"date-time":"2018-02-19T11:01:30Z","timestamp":1519038090000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/156952\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,16]]},"references-count":0,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2018,2,16]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1381612823666171109101851","relation":{},"ISSN":["1381-6128"],"issn-type":[{"value":"1381-6128","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2,16]]}}}